Literature DB >> 6639136

Pulmonary eosinophilia associated with carbamazepine.

J Tolmie, C R Steer, A T Edmunds.   

Abstract

An 8 year old girl treated with carbamazepine developed eczema, wheeze, and evidence of pulmonary eosinophilia. Single dose challenge confirmed allergy to this drug. This reaction should be considered in patients being treated with carbamazepine who develop respiratory symptoms.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6639136      PMCID： PMC1628270          DOI： 10.1136/adc.58.10.833

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  Acute hypersensitivity pneumonitis associated with carbamazepine therapy.

Authors:  W C Stephan; R D Parks; B Tempest
Journal:  Chest       Date:  1978-10       Impact factor: 9.410

2.  Lymphocyte-stimulation tests and patch tests to carbamazepine hypersensitivity.

Authors:  J Houwerzijl; G C De Gast; J P Nater; M T Esselink; H O Nieweg
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

3.  Pulmonary eosinophilia and asthma associated with carbamazepine.

Authors:  T Lee; G M Cochrane; P Amlot
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-07

4.  Acute pulmonary hypersensitivity to carbamazepine.

Authors:  S A Cullinan; G C Bower
Journal:  Chest       Date:  1975-10       Impact factor: 9.410

5.  [Case of carbamazepine-induced interstitial pneumonia].

Authors:  M Schmidt; E Brugger
Journal:  Med Klin       Date:  1980-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.